158 related articles for article (PubMed ID: 7884585)
1. Loss of membranous E-cadherin expression in pancreatic cancer: correlation with lymph node metastasis, high grade, and advanced stage.
Pignatelli M; Ansari TW; Gunter P; Liu D; Hirano S; Takeichi M; Klöppel G; Lemoine NR
J Pathol; 1994 Dec; 174(4):243-8. PubMed ID: 7884585
[TBL] [Abstract][Full Text] [Related]
2. Aberrant E-cadherin expression associated with loss of differentiation and advanced stage in human pancreatic cancer.
Karayiannakis AJ; Syrigos KN; Chatzigianni E; Papanikolaou S; Alexiou D; Kalahanis N; Rosenberg T; Bastounis E
Anticancer Res; 1998; 18(6A):4177-80. PubMed ID: 9891464
[TBL] [Abstract][Full Text] [Related]
3. Loss of membrane localization and aberrant nuclear E-cadherin expression correlates with invasion in pancreatic endocrine tumors.
Chetty R; Serra S; Asa SL
Am J Surg Pathol; 2008 Mar; 32(3):413-9. PubMed ID: 18300809
[TBL] [Abstract][Full Text] [Related]
4. Relationship between expressions of E-cadherin and alpha-catenin and biological behaviors of human pancreatic cancer.
Li YJ; Meng YX; Ji XR
Hepatobiliary Pancreat Dis Int; 2003 Aug; 2(3):471-7. PubMed ID: 14599963
[TBL] [Abstract][Full Text] [Related]
5. E-cadherin expression as a differentiation marker in gastric cancer.
Karayiannakis AJ; Syrigos KN; Chatzigianni E; Papanikolaou S; Karatzas G
Hepatogastroenterology; 1998; 45(24):2437-42. PubMed ID: 9951940
[TBL] [Abstract][Full Text] [Related]
6. Expression of beta-catenin, alpha-catenin, and E-cadherin in Barrett's esophagus and esophageal adenocarcinomas.
Washington K; Chiappori A; Hamilton K; Shyr Y; Blanke C; Johnson D; Sawyers J; Beauchamp D
Mod Pathol; 1998 Sep; 11(9):805-13. PubMed ID: 9758359
[TBL] [Abstract][Full Text] [Related]
7. E-cadherin and DAP kinase in pancreatic adenocarcinoma and corresponding lymph node metastases.
Dansranjavin T; Möbius C; Tannapfel A; Bartels M; Wittekind C; Hauss J; Witzigmann H
Oncol Rep; 2006 May; 15(5):1125-31. PubMed ID: 16596173
[TBL] [Abstract][Full Text] [Related]
8. An immunohistochemical examination of the expression of E-cadherin, alpha- and beta/gamma-catenins, and alpha2- and beta1-integrins in invasive breast cancer.
Gonzalez MA; Pinder SE; Wencyk PM; Bell JA; Elston CW; Nicholson RI; Robertson JF; Blamey RW; Ellis IO
J Pathol; 1999 Apr; 187(5):523-9. PubMed ID: 10398116
[TBL] [Abstract][Full Text] [Related]
9. Expression of E-cadherin in human ductal breast cancer carcinoma in situ, invasive carcinomas, their lymph node metastases, their distant metastases, carcinomas with recurrence and in recurrence.
Jeschke U; Mylonas I; Kuhn C; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
Anticancer Res; 2007; 27(4A):1969-74. PubMed ID: 17649807
[TBL] [Abstract][Full Text] [Related]
10. Expression of CD44v6 but not E-cadherin or beta-catenin influences prognosis in primary pulmonary adenocarcinoma.
Ramasami S; Kerr KM; Chapman AD; King G; Cockburn JS; Jeffrey RR
J Pathol; 2000 Dec; 192(4):427-32. PubMed ID: 11113858
[TBL] [Abstract][Full Text] [Related]
11. The loss of E-cadherin, alpha- and beta-catenin expression is associated with metastasis and poor prognosis in invasive breast cancer.
Yoshida R; Kimura N; Harada Y; Ohuchi N
Int J Oncol; 2001 Mar; 18(3):513-20. PubMed ID: 11179480
[TBL] [Abstract][Full Text] [Related]
12. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
[TBL] [Abstract][Full Text] [Related]
13. Expression of vascular endothelial growth factor, matrix metalloproteinase-9 and E-cadherin in the process of lymph node metastasis in oesophageal cancer.
Sato F; Shimada Y; Watanabe G; Uchida S; Makino T; Imamura M
Br J Cancer; 1999 Jul; 80(9):1366-72. PubMed ID: 10424737
[TBL] [Abstract][Full Text] [Related]
14. Expression of the E-cadherin/catenin (alpha-, beta-, and gamma-) complex correlates with the macroscopic appearance of early gastric cancer.
Ohene-Abuakwa Y; Noda M; Perenyi M; Kobayashi N; Kashima K; Hattori T; Pignatelli M
J Pathol; 2000 Dec; 192(4):433-9. PubMed ID: 11113859
[TBL] [Abstract][Full Text] [Related]
15. E-cadherin expression in prostate cancer: a broad survey using high-density tissue microarray technology.
Rubin MA; Mucci NR; Figurski J; Fecko A; Pienta KJ; Day ML
Hum Pathol; 2001 Jul; 32(7):690-7. PubMed ID: 11486167
[TBL] [Abstract][Full Text] [Related]
16. Expression of E-cadherin, P-cadherin and N-cadherin in oral squamous cell carcinoma: correlation with the clinicopathologic features and patient outcome.
Pyo SW; Hashimoto M; Kim YS; Kim CH; Lee SH; Johnson KR; Wheelock MJ; Park JU
J Craniomaxillofac Surg; 2007 Jan; 35(1):1-9. PubMed ID: 17296306
[TBL] [Abstract][Full Text] [Related]
17. Altered expression and function of E-cadherin in cervical intraepithelial neoplasia and invasive squamous cell carcinoma.
Vessey CJ; Wilding J; Folarin N; Hirano S; Takeichi M; Soutter P; Stamp GW; Pignatelli M
J Pathol; 1995 Jun; 176(2):151-9. PubMed ID: 7636625
[TBL] [Abstract][Full Text] [Related]
18. Re-expression of the cadherin-catenin complex in lymph nodes with metastasis in advanced gastric cancer: the relationship with patient survival.
Liu J; Ikeguchi M; Nakamura S; Kaibara N
J Exp Clin Cancer Res; 2002 Mar; 21(1):65-71. PubMed ID: 12071532
[TBL] [Abstract][Full Text] [Related]
19. Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis.
Oka H; Shiozaki H; Kobayashi K; Inoue M; Tahara H; Kobayashi T; Takatsuka Y; Matsuyoshi N; Hirano S; Takeichi M
Cancer Res; 1993 Apr; 53(7):1696-701. PubMed ID: 8453644
[TBL] [Abstract][Full Text] [Related]
20. E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis.
Schipper JH; Frixen UH; Behrens J; Unger A; Jahnke K; Birchmeier W
Cancer Res; 1991 Dec; 51(23 Pt 1):6328-37. PubMed ID: 1933895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]